India Launches Anti-Dumping Probe into Chinese Glycine Imports
India's trade remedies body has begun an anti-dumping investigation into Glycine imports from China, following concerns from domestic manufacturers.

India has initiated an anti-dumping investigation into imports of Glycine, a crucial chemical compound, originating from China. The Directorate General of Trade Remedies (DGTR), operating under the Ministry of Commerce and Industry, announced the commencement of this probe following concerns raised by domestic manufacturers regarding unfair trade practices.
The investigation aims to ascertain whether Glycine from China is being 'dumped' into the Indian market. Dumping occurs when goods are exported at a price lower than their normal value, typically the price at which they are sold in the exporting country's domestic market or their cost of production. Such practices can severely undermine the competitiveness of local industries.
Should the DGTR establish that these dumped imports have caused "material injury" to Indian producers, it would recommend the imposition of anti-dumping duties. These duties are designed to offset the price disadvantage faced by domestic players. The final decision to levy any such duties, however, rests with the Union Finance Ministry, which reviews the DGTR's findings and recommendations.
Glycine is an important amino acid with diverse applications across various sectors. It is extensively used in the pharmaceutical industry for drug synthesis, in the food and beverage sector as a flavour enhancer and preservative, and in the animal feed industry as a nutritional supplement. The domestic production of Glycine is vital for India's self-reliance in these critical areas, making the protection of local manufacturers a key objective of this investigation.

US President Trump Unveils Venezuela Oil Deal, Aims to Lower Global Energy Prices

Samsung India’s Profit Plunges 36% to ₹7,228 Crore in FY26 Amidst Stiff Competition
